Literature DB >> 17434799

Definition and classification of abnormal vaginal flora.

Gilbert G G Donders1.   

Abstract

Studying the vaginal microflora is not only fascinating, with many discoveries to be made, it is also a very practical way to help women get rid of bothersome and sometimes dangerous infections. Gram-stained vaginal preparations, Pap smears, specific cultures, and nucleic acid detection techniques can be used to diagnose the constituents of the vaginal flora, but in trained hands office-based microscopy of a fresh vaginal smear, preferably using a x400 magnification phase-contrast microscope, allows almost every diagnosis and combination of diagnoses imaginable. In this chapter I will address the pros and cons of the tools that are in use to study vaginal flora, and discuss the different types of bacterial flora and the difficulties encountered in reaching the correct diagnosis of pathological conditions. The 'intermediate flora' is addressed separately, and a new entity--'aerobic vaginitis'--is discussed. Future research should focus on the interaction between infecting microorganisms and host defence mechanisms, as both together generate the pathogenicity of these conditions.

Entities:  

Mesh:

Year:  2007        PMID: 17434799     DOI: 10.1016/j.bpobgyn.2007.01.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  51 in total

1.  The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.

Authors:  G Donders; G Bellen; J Ausma; L Verguts; J Vaneldere; P Hinoul; M Borgers; D Janssens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-28       Impact factor: 3.267

2.  Heterogeneity of vaginal microbial communities within individuals.

Authors:  Tae Kyung Kim; Susan M Thomas; Mengfei Ho; Shobha Sharma; Claudia I Reich; Jeremy A Frank; Kathleen M Yeater; Diana R Biggs; Noriko Nakamura; Rebecca Stumpf; Steven R Leigh; Richard I Tapping; Steven R Blanke; James M Slauch; H Rex Gaskins; Jon S Weisbaum; Gary J Olsen; Lois L Hoyer; Brenda A Wilson
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

3.  Cytology in the differential diagnosis of vaginitis.

Authors:  Graeme J Dennerstein
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

4.  Influence of contraceptive choice on vaginal bacterial and fungal microflora.

Authors:  G Donders; G Bellen; D Janssens; B Van Bulck; P Hinoul; J Verguts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-09       Impact factor: 3.267

5.  Selecting anti-microbial treatment of aerobic vaginitis.

Authors:  Gilbert G G Donders; Katerina Ruban; Gert Bellen
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

6.  A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.

Authors:  JoonHo Lee; Roberto Romero; Sun Min Kim; Piya Chaemsaithong; Chan-Wook Park; Joong Shin Park; Jong Kwan Jun; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-09-16

Review 7.  Understanding vaginal microbiome complexity from an ecological perspective.

Authors:  Roxana J Hickey; Xia Zhou; Jacob D Pierson; Jacques Ravel; Larry J Forney
Journal:  Transl Res       Date:  2012-03-06       Impact factor: 7.012

8.  Accuracy of vaginal symptom self-diagnosis algorithms for deployed military women.

Authors:  Nancy A Ryan-Wenger; Jeremy L Neal; Ashley S Jones; Nancy K Lowe
Journal:  Nurs Res       Date:  2010 Jan-Feb       Impact factor: 2.381

9.  Easiness of use and validity testing of VS-SENSE device for detection of abnormal vaginal flora and bacterial vaginosis.

Authors:  Gilbert G G Donders; Camila Marconi; Gert Bellen
Journal:  Infect Dis Obstet Gynecol       Date:  2010-10-07

10.  Increased vaginal pH in Ugandan women: what does it indicate?

Authors:  G G G Donders; A Gonzaga; C Marconi; F Donders; T Michiels; N Eggermont; G Bellen; J Lule; J Byamughisa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-14       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.